Format

Send to

Choose Destination
Curr Cardiol Rep. 2017 Sep 19;19(11):110. doi: 10.1007/s11886-017-0916-0.

Sleep and Cardio-Metabolic Disease.

Author information

1
Warwick Medical School, Division of Health Sciences, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK. f.p.cappuccio@warwick.ac.uk.
2
University Hospitals Coventry and Warwickshire NHS Trust, Clifford Bridge Road, Coventry, CV2 2DX, UK. f.p.cappuccio@warwick.ac.uk.
3
Warwick Medical School, Division of Health Sciences, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK.

Abstract

PURPOSE OF REVIEW:

This review summarises and discusses the epidemiological evidence suggesting a causal relationship between sleep duration and cardio-metabolic risk and outcomes in population.

RECENT FINDINGS:

Sleep duration is affected by a variety of cultural, social, psychological, behavioural, pathophysiological and environmental influences. Changes in modern society-like longer working hours, more shift-work, 24/7 availability of commodities and 24-h global connectivity-have been associated with a gradual reduction in sleep duration and sleeping patterns across westernised populations. We review the evidence of an association between sleep disturbances and the development of cardio-metabolic risk and disease and discuss the implications for causality of these associations. Prolonged curtailment of sleep duration is a risk factor for the development of obesity, diabetes, hypertension, heart disease and stroke and may contribute, in the long-term, to premature death.

KEYWORDS:

Cardiovascular disease; Diabetes; Hypertension; Naps; Obesity; Sleep deprivation

PMID:
28929340
PMCID:
PMC5605599
DOI:
10.1007/s11886-017-0916-0
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center